Please note: CPS is under development and not yet FDA-approved.
Sensydia, a clinical-stage non-invasive cardiac assessment company, announced today that University of Minnesota investigators presented positive clinical findings from a recent study evaluating the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback